CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+13.82%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.5B
AUM Growth
+$378M
(+2.7%)
Cap. Flow
+$273M
Cap. Flow
% of AUM
1.89%
Top 10 Holdings %
Top 10 Hldgs %
26.25%
Holding
738
New
61
Increased
261
Reduced
285
Closed
31
Top Buys
| 1 |
Visa
V
|
+$77.8M |
| 2 |
Gilead Sciences
GILD
|
+$59.3M |
| 3 |
Microsoft
MSFT
|
+$46.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$40.2M |
| 5 |
Nu Holdings
NU
|
+$39.1M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$112M |
| 2 |
Royal Bank of Canada
RY
|
+$51.1M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$42.8M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$38.9M |
| 5 |
Merck
MRK
|
+$33.3M |
Sector Composition
| 1 | Technology | 30.32% |
| 2 | Healthcare | 28.88% |
| 3 | Consumer Discretionary | 8.63% |
| 4 | Financials | 8.52% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Fortinet
FTNT
$61.2B
| $5.09M | 0.04% |
86,970
-74,796
| -46% | -$4.38M |
|
327
Schrodinger
SDGR
$1.43B
| $5.08M | 0.04% |
142,000
+72,000
| +103% | +$2.58M |
|
328
Blackstone
BX
$135B
| $5.03M | 0.03% |
38,410
+174
| +0.5% | +$22.8K |
|
329
ICICI Bank
IBN
$114B
| $4.96M | 0.03% |
208,000
+74,000
| +55% | +$1.76M |
|
330
Caribou Biosciences
CRBU
$171M
| $4.93M | 0.03% |
+860,024
| New | +$4.93M |
|
|
SAGE
331
DELISTED
Sage Therapeutics
SAGE
| $4.92M | 0.03% |
227,000
| – | – |
|
332
Labcorp
LH
$23.1B
| $4.92M | 0.03% |
21,642
+2,708
| +14% | +$616K |
|
333
Montrose Environmental
MEG
$1.01B
| $4.81M | 0.03% |
149,650
+11,875
| +9% | +$382K |
|
334
Autoliv
ALV
$9.66B
| $4.69M | 0.03% |
42,606
| – | – |
|
|
BPMC
335
DELISTED
Blueprint Medicines
BPMC
| $4.63M | 0.03% |
50,221
-85,001
| -63% | -$7.84M |
|
336
Disc Medicine
IRON
$2.1B
| $4.62M | 0.03% |
+80,000
| New | +$4.62M |
|
337
Kinder Morgan
KMI
$59.2B
| $4.57M | 0.03% |
258,917
-8,595
| -3% | -$152K |
|
338
FedEx
FDX
$53.3B
| $4.55M | 0.03% |
17,998
+513
| +3% | +$130K |
|
339
Carrier Global
CARR
$54B
| $4.5M | 0.03% |
78,368
+2,847
| +4% | +$164K |
|
340
Treace Medical Concepts
TMCI
$467M
| $4.46M | 0.03% |
350,000
-77,972
| -18% | -$994K |
|
341
RenaissanceRe
RNR
$11.2B
| $4.42M | 0.03% |
22,557
-10,548
| -32% | -$2.07M |
|
|
VERV
342
DELISTED
Verve Therapeutics
VERV
| $4.32M | 0.03% |
+310,000
| New | +$4.32M |
|
343
EOG Resources
EOG
$64.1B
| $4.31M | 0.03% |
35,595
-106
| -0.3% | -$12.8K |
|
344
Akero Therapeutics
AKRO
$3.57B
| $4.3M | 0.03% |
184,000
+84,000
| +84% | +$1.96M |
|
345
Travelers Companies
TRV
$61.6B
| $4.27M | 0.03% |
22,429
-1,022
| -4% | -$195K |
|
346
BioNTech
BNTX
$24.5B
| $4.25M | 0.03% |
40,303
-20,000
| -33% | -$2.11M |
|
347
Day One Biopharmaceuticals
DAWN
$759M
| $4.23M | 0.03% |
290,014
| – | – |
|
348
Eversource Energy
ES
$23.7B
| $4.2M | 0.03% |
68,104
-31,487
| -32% | -$1.94M |
|
349
Williams Companies
WMB
$70.3B
| $4.19M | 0.03% |
120,355
+3,764
| +3% | +$131K |
|
350
W.W. Grainger
GWW
$47.6B
| $4.19M | 0.03% |
5,056
-18,751
| -79% | -$15.5M |
|